Clinical trials
Diabetic clinical trials
Below are recruiting diabetic clinical trials, each written for real people, not researchers. We’re tracking 2,211 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06703788RecruitingPhase 1/Phase 2
Traditional Chinese Medicine Day Care for Metabolic Syndrome
This trial tests a day care program that combines traditional Chinese medicine with regular care for people with metabolic syndrome. It aims to see if this approach helps improve your health better than standard care alone.
TaoyuanAges 20–75 - NCT06706635Recruiting
Better info for aortic stenosis patients before TAVI
This trial tests whether giving extra information before heart valve replacement (TAVI) helps patients feel more informed and improves their reported outcomes. If you have severe aortic stenosis and are planning to get a TAVI, this study may be for you.
Bad OeynhausenAges 18 years+ - NCT07688278Recruiting
Diabetes screening for people with advanced gum disease
This trial tests whether checking blood sugar (HbA1c) at the dentist can find undiagnosed diabetes. It is for adults with advanced periodontitis (severe gum disease) who have not already been told they have diabetes.
SkåneAges 18 years+ - NCT07354477RecruitingPhase 2
New eye drop for glaucoma and diabetic retinopathy
This trial tests a new eye drop (QLS-111) to see if it improves blood flow in the back of the eye. It may help people with mild to moderate glaucoma or stable diabetic retinopathy by reducing pressure inside the eye and nourishing the optic nerve.
Palo Alto, CaliforniaAges 18 years+ - NCT04297592Enrolling by invitationPhase 4
Antibiotics to prevent infection after hip or knee replacement
This trial studies whether giving antibiotics before and/or after surgery can lower the chance of a serious joint infection after elective hip or knee replacement. It’s aimed at people at higher risk for infection.
Iowa City, IowaAges 18–99 - NCT06708780RecruitingPhase 1
Treg cell therapy for type 1 diabetes
This trial tests whether giving your own regulatory T cells (a type of immune cell) back to you can help slow or stop the immune attack on your pancreas in type 1 diabetes. It is for people aged 8 to 65 who still make some insulin.
Nanjing, JiangsuAges 8–65 - NCT06721429Recruiting
Dual-task training for balance and health in type 2 diabetes
This trial tests whether doing two tasks at once (like walking while talking) can improve balance, exercise ability, thinking, and quality of life for people with type 2 diabetes. It compares this training to standard care to see if it offers extra benefits.
BartınAges 65 years+ - NCT06724172Recruiting
Comparing health programs for pregnant mothers from diverse backgrounds
This study tests two different health programs for pregnant women to see which one helps mothers and babies more. You may join if you are early in your pregnancy, identify as Black, Hispanic, or have Medicaid, and speak English or Spanish.
Palo Alto, CaliforniaAges 18 years+ - NCT06724406Recruiting
Family-centered weight loss for Black adults
This trial tests a weight loss program for Black adults and a family partner. You and a family member work together to lose weight with support from a smartphone or computer.
Chapel Hill, North CarolinaAges 18–75 - NCT06726590Recruiting
Gene testing for better medication outcomes
This study collects blood, urine, and cheek swabs, along with health information, to see how your genes affect your response to medications. You may be eligible if you take many medications or are on blood pressure or depression medication.
Bryan, TexasAges 18 years+ - NCT06735599Recruiting
Wild blueberries for blood pressure health
This study tests whether eating wild blueberries can improve your gut, brain, and heart health if you have high blood pressure. You'll eat blueberries daily for several weeks and have checkups to see how your body responds.
Atlanta, GeorgiaAges 45–65 - NCT06742060Recruiting
Copeptin levels after brain surgery in children
This study follows children after brain surgery to see how a substance called copeptin (a marker in the blood) changes and whether it can help doctors spot a condition that causes too much thirst and urination (diabetes insipidus) early. It may lead to better care for children in the ICU.
Shanghai, Shanghai MunicipalityAges 4 weeks–18 years - NCT06748365Recruiting
Ferritin levels and recovery in diabetic ketoacidosis
This study looks at whether the level of a protein called ferritin in your blood can help predict how well you recover from diabetic ketoacidosis (DKA). If you have DKA and are over 18, you may be able to join.
Sohag, Sohag GovernorateAges 18 years+ - NCT06752772Recruiting
Wearable health coaching for blood pressure and weight
This study tests a digital health coaching program that uses a smartwatch and smartphone to help people manage conditions like high blood pressure, pre-diabetes, or weight. It aims to see if wearable technology can improve your health with personalized coaching.
SingaporeAges 21–75 - NCT06759701RecruitingEarly Phase 1
Weight loss drug before prostate cancer surgery pilot study
This study tests if taking tirzepatide (a weight loss medicine) before prostate removal surgery is safe and helpful for overweight men with intermediate-risk prostate cancer. It aims to see if losing weight can improve surgery outcomes.
Houston, TexasAges 18 years+ - NCT06760845Recruiting
Using light to diagnose kidney disease
This trial uses a special light technique (Raman spectroscopy) to help diagnose different types of kidney disease. It may provide a faster, less invasive way to understand your condition.
Jinan, ShandongAges Any age - NCT06764069Recruiting
New sensor for continuous blood sugar monitoring
This study tests a new glucose sensor placed inside a blood vessel to see how well it measures blood sugar. If you have diabetes and use intensive insulin therapy, this could be a way to help improve monitoring.
São Paulo, BrazilAges 21–75 - NCT06764719Recruiting
Hair follicles for cell therapy
This trial tests if special hair follicles can be used for cell replacement therapy in disease. It may help people with certain medical conditions.
Toronto, QuebecAges 18–80 - NCT06770621Recruiting
Glucagon response study in new type 1 diabetes
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
Brussels, Woluwe-saint-lambertAges 2–30 - NCT06775028Recruiting
Integrated care for older adults with atrial fibrillation
This trial is testing a new approach to care for older adults with atrial fibrillation (an irregular heartbeat) who also have other health conditions. It aims to see if a more integrated, team-based care plan helps improve their overall health and quality of life.
HaskovoAges 65 years+ - NCT06781775RecruitingPhase 4
Metformin vs insulin for gestational diabetes
This trial compares two medicines—metformin pills and insulin shots—to see which works better for controlling blood sugar in gestational diabetes. You may be able to join if you have gestational diabetes that needs treatment and are willing to take either medicine.
Charlottesville, VirginiaAges 18–50 - NCT06782139RecruitingPhase 4
Enavogliflozin for heart health in obesity and diabetes
This trial tests if Enavogliflozin, a medication for diabetes, can improve blood flow in the small vessels of the heart and overall heart function in people with obesity or diabetes. You may join if you have obesity or diabetes and have had a recent heart test.
SeoulAges 20–79 - NCT06784674Recruiting
Pregnancy belly shape study for expectant mothers
This study uses MRI to look at how a mother's belly changes during and after pregnancy. It aims to understand normal changes and help plan future healthcare.
Austin, TexasAges 18–54 - NCT06789705Recruiting
MDMA for people with vasopressin deficiency
This study tests whether a low dose of MDMA, compared to a placebo, changes oxytocin levels in people with a condition called arginine vasopressin deficiency (also known as central diabetes insipidus). The goal is to understand the role of oxytocin in this condition and explore potential treatment insights.
BaselAges 18 years+
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic?
- Yes. Clin2 currently lists 2,211 recruiting diabetic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.